Paper33397809
Prediction of Alzheimer's disease-specific phospholipase c gamma-1 SNV by deep learning-based approach for high-throughput screening.
Kim SH and 7 others. Proc Natl Acad Sci U S A, 2021. Cited by 17 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Prediction of Alzheimer's disease-specific phospholipase c gamma-1 SNV by deep learning-based approach for high-throughput screening. Papers, record 33397809. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/33397809
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Prediction of Alzheimer's disease-specific phospholipase c gamma-1 SNV by deep learning-based approach for high-throughput screening.
- PubMed
Topics16
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Alzheimer Disease | Major topic |
| Deep Learning | Major topic |
| Genetic Predisposition to Disease | Major topic |
| Phospholipase C gamma | Major topic |
| Animals | |
| Computer Simulation | |
| Disease Models, Animal | |
| Exons | |
| Genome, Human | |
| Genome-Wide Association Study | |
| High-Throughput Screening Assays | |
| Humans | |
| Mice | |
| Polymorphism, Single Nucleotide | |
| RNA Splicing | |
| RNA, Messenger |
Source PubMed
Comments and corrections1
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
| Kind | PMID | Title | In Papers |
|---|---|---|---|
| Erratum in | 33,579,793 | Correction for Kim et al., Prediction of Alzheimer's disease-specific phospholipase c gamma-1 SNV by deep learning-based approach for high-throughput screening. | https://conductscience.org/library/papers/33579793 |
Source PubMed
References49
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 24,360,275 | Rapid and pervasive changes in genome-wide enhancer usage during mammalian development. | Cell | 2013 | https://conductscience.org/library/papers/24360275 | PubMed |
| 2 | 30,224,412 | Netrin-1/DCC-mediated PLCγ1 activation is required for axon guidance and brain structure development. | EMBO Rep | 2018 | https://conductscience.org/library/papers/30224412 | PubMed |
| 3 | 24,119,843 | Super-enhancers in the control of cell identity and disease. | Cell | 2013 | https://conductscience.org/library/papers/24119843 | PubMed |
| 4 | 27,104,977 | On the Dependency of Cellular Protein Levels on mRNA Abundance. | Cell | 2016 | https://conductscience.org/library/papers/27104977 | PubMed |
| 5 | 2,459,119 | Monoclonal antibodies to three phospholipase C isozymes from bovine brain. | J Biol Chem | 1988 | https://conductscience.org/library/papers/2459119 | PubMed |
| 6 | 30,711,010 | Alzheimer's disease phospholipase C-gamma-2 (PLCG2) protective variant is a functional hypermorph. | Alzheimers Res Ther | 2019 | https://conductscience.org/library/papers/30711010 | PubMed |
| 7 | 25,784,052 | Mechanisms and Regulation of Alternative Pre-mRNA Splicing. | Annu Rev Biochem | 2015 | https://conductscience.org/library/papers/25784052 | PubMed |
| 8 | 25,263,592 | Enhancer RNA facilitates NELF release from immediate early genes. | Mol Cell | 2014 | https://conductscience.org/library/papers/25263592 | PubMed |
| 9 | 27,188,934 | Alzheimer's disease. | Nat Rev Dis Primers | 2015 | https://conductscience.org/library/papers/27188934 | PubMed |
| 10 | 17,442,445 | Coevolution of genomic intron number and splice sites. | Trends Genet | 2007 | https://conductscience.org/library/papers/17442445 | PubMed |
| 11 | 30,466,729 | RNA Splicing and Disease: Animal Models to Therapies. | Trends Genet | 2019 | https://conductscience.org/library/papers/30466729 | PubMed |
| 12 | 20,083,631 | Phenotypic plasticity in development and evolution: facts and concepts. Introduction. | Philos Trans R Soc Lond B Biol Sci | 2010 | https://conductscience.org/library/papers/20083631 | PubMed |
| 13 | 25,657,249 | Genomic variation. Impact of regulatory variation from RNA to protein. | Science | 2015 | https://conductscience.org/library/papers/25657249 | PubMed |
| 14 | 19,679,070 | The role of apolipoprotein E in Alzheimer's disease. | Neuron | 2009 | https://conductscience.org/library/papers/19679070 | PubMed |
| 15 | 26,136,662 | Histone Acetylation Modifiers in the Pathogenesis of Alzheimer's Disease. | Front Cell Neurosci | 2015 | https://conductscience.org/library/papers/26136662 | PubMed |
| 16 | 31,881,982 | SpliceFinder: ab initio prediction of splice sites using convolutional neural network. | BMC Bioinformatics | 2019 | https://conductscience.org/library/papers/31881982 | PubMed |
| 17 | 28,488,700 | Alternative splicing as a regulator of development and tissue identity. | Nat Rev Mol Cell Biol | 2017 | https://conductscience.org/library/papers/28488700 | PubMed |
| 18 | 22,909,801 | Function of alternative splicing. | Gene | 2013 | https://conductscience.org/library/papers/22909801 | PubMed |
| 19 | 22,229,116 | Neuropathological alterations in Alzheimer disease. | Cold Spring Harb Perspect Med | 2011 | https://conductscience.org/library/papers/22229116 | PubMed |
| 20 | 31,243,043 | Prevalence of BTK and PLCG2 mutations in a real-life CLL cohort still on ibrutinib after 3 years: a FILO group study. | Blood | 2019 | https://conductscience.org/library/papers/31243043 | PubMed |
Cited by13
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 17 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41,502,663 | Machine Learning Approaches for Optimizing Drug Combinations in Neurodegenerative Diseases: A Brief Review. | ACS Omega | 2025 | https://conductscience.org/library/papers/41502663 | PubMed |
| 41,184,364 | A multivariate approach to identify association between peripheral blood DNA methylation and cerebrospinal fluid biomarkers of Alzheimer disease. | Sci Rep | 2025 | https://conductscience.org/library/papers/41184364 | PubMed |
| 40,052,173 | A review of AI-based radiogenomics in neurodegenerative disease. | Front Big Data | 2025 | https://conductscience.org/library/papers/40052173 | PubMed |
| 39,630,834 | Deep learning analysis of fMRI data for predicting Alzheimer's Disease: A focus on convolutional neural networks and model interpretability. | PLoS One | 2024 | https://conductscience.org/library/papers/39630834 | PubMed |
| 39,572,036 | The early diagnosis of Alzheimer's disease: Blood-based panel biomarker discovery by proteomics and metabolomics. | CNS Neurosci Ther | 2024 | https://conductscience.org/library/papers/39572036 | PubMed |
| 38,871,819 | Molecular insights into regulatory RNAs in the cellular machinery. | Exp Mol Med | 2024 | https://conductscience.org/library/papers/38871819 | PubMed |
| 38,778,723 | A new genetic diagnosis strategy for paroxysmal kinesigenic dyskinesia: Targeted high-throughput detection of PRRT2 gene c.649 locus. | Mol Genet Genomic Med | 2024 | https://conductscience.org/library/papers/38778723 | PubMed |
| 36,948,701 | Molecular regulation of PLCβ signaling. | Methods Enzymol | 2023 | https://conductscience.org/library/papers/36948701 | PubMed |
| 36,448,305 | Cryptic mutations of PLC family members in brain disorders: recent discoveries and a deep-learning-based approach. | Brain | 2023 | https://conductscience.org/library/papers/36448305 | PubMed |
| 36,276,634 | Trans-channel fluorescence learning improves high-content screening for Alzheimer's disease therapeutics. | Nat Mach Intell | 2022 | https://conductscience.org/library/papers/36276634 | PubMed |
| 34,944,511 | New Variants of the Cytochrome P450 2R1 (CYP2R1) Gene in Individuals with Severe Vitamin D-Activating Enzyme 25(OH)D Deficiency. | Biomolecules | 2021 | https://conductscience.org/library/papers/34944511 | PubMed |
| 34,573,290 | Performance Evaluation of SpliceAI for the Prediction of Splicing of NF1 Variants. | Genes (Basel) | 2021 | https://conductscience.org/library/papers/34573290 | PubMed |
| 34,360,676 | Deep Learning with Neuroimaging and Genomics in Alzheimer's Disease. | Int J Mol Sci | 2021 | https://conductscience.org/library/papers/34360676 | PubMed |
Genes11
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| APP | 351 | PubTator's text mining | https://conductscience.org/library/genes/351 | NCBI Gene |
| BIN1 | 274 | PubTator's text mining | https://conductscience.org/library/genes/274 | NCBI Gene |
| HSPG2 | 3,339 | PubTator's text mining | https://conductscience.org/library/genes/3339 | NCBI Gene |
| INS | 3,630 | PubTator's text mining | https://conductscience.org/library/genes/3630 | NCBI Gene |
| LGR5 | 8,549 | PubTator's text mining | https://conductscience.org/library/genes/8549 | NCBI Gene |
| LINC02605 | 112,935,892 | PubTator's text mining | https://conductscience.org/library/genes/112935892 | NCBI Gene |
| PLCB1 | 23,236 | PubTator's text mining | https://conductscience.org/library/genes/23236 | NCBI Gene |
| PLCB2 | 5,330 | PubTator's text mining | https://conductscience.org/library/genes/5330 | NCBI Gene |
| PLCB3 | 5,331 | PubTator's text mining | https://conductscience.org/library/genes/5331 | NCBI Gene |
| PLCB4 | 5,332 | PubTator's text mining | https://conductscience.org/library/genes/5332 | NCBI Gene |
| PLCG1 | 5,335 | PubTator's text mining | https://conductscience.org/library/genes/5335 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/33397809
GET https://conductscience.org/api/papers/v1/33397809/references?page=2